Best for: Adults with excess visceral (abdominal) fat, metabolic syndrome, or those who dont qualify for GLP-1 therapy
Concurring with our findings, it is well recognized that, besides genetics and metabolic programming, the greater predisposition to childhood obesity induced by PO might be related to lifestyle habits, since children grown by families with obesity often have lower preference for vegetables and higher preference for fatty/sugary foods [52]
So while the relative risk seems high, the absolute number of people affected is relatively small
Plant Physiol Biochem 166:874886
Research in the Journal of Biological Chemistry demonstrated that the probiotic VSL#3 promotes GLP-1 release from intestinal L-cells via butyrate, a short-chain fatty acid produced when gut bacteria ferment fiber
Mochi Health is a telehealth company based in San Francisco that connects patients with licensed providers for weight loss treatment, including compounded and brand-name GLP-1 medications like tirzepatide and semaglutide